Movement Alert|ASMPT Declines 3.22% in Regular Trading, Strong US Non-Farm Data Reignites Rate Hike Fears Weighing on HK Stocks

Market Focus
Sep 08

On September 8, ASMPT declined 3.22% in regular trading, trading at 162.2 HKD/share, with turnover of 267 million HKD.

On the news front, stronger-than-expected US non-farm payrolls data reignited expectations of further rate hikes, placing broad short-term pressure on Hong Kong equities. ASMPT, despite robust fundamentals, faced headwinds from the macro backdrop alongside lingering profit-taking pressure following a cumulative rally exceeding 20% in August.

The stock had previously pulled back after its mid-year report revealed a gap between continuing-operations adjusted net profit of 973 million HKD (up 230.5% YoY) and the consolidated figure of 806 million HKD due to the NEXX business divestiture in June. Additionally, major shareholder The Capital Group reduced its stake from 9.17% to 8.75% in late July, adding to cautious sentiment. Multiple investment banks maintain bullish ratings, with Bank of America assigning a buy rating and a 310 HKD target price, while JP Morgan maintains an overweight rating with a 225 HKD target, both significantly above current levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10